Not currently recruiting at UC Irvine
SHOrt Course Radiation and TASOX (TAS102 Plus Oxaliplatin) Chemotherapy in Operable Rectal Cancer
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Orange, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Jason A. Zell, DO, MPH, MS
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UC Irvine
- Jason A. Zell, DO, MPH, MS
Professor, Medicine, School of Medicine. Authored (or co-authored) 91 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Providence Health & Services
- ID
- NCT04417699
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 27 study participants
- Last Updated